President Trump recently signed into law some of the most dramatic changes to our healthcare system since the Affordable Care Act (ACA) was enacted in 2010. CHIR’s Leila Sullivan provides a roundup of recent research projecting what the new law means for coverage, affordability, and uncompensated care.
In May, we welcomed spring blooms and warm weather, while staying engaged with the latest health policy research. This month we read about potential effects of the reconciliation bill on provider revenue and uncompensated care, Rhode Island’s affordability standards and their effects on hospital prices, and coverage retention and plan switching following changes in premiums.
The Trump administration’s proposed “Marketplace Integrity” rule has generated almost 26,000 public comments. In this fourth in a 4-part blog series summarizing comments from a range of key stakeholders, CHIR’s Leila Sullivan digs into the responses and recommendations from consumer and patient advocate organizations.
With infectious diseases such as measles on the rise, many Americans are wondering what they can do to protect themselves and loved ones against illness. CHIR’s Leila Sullivan breaks down what vaccines, boosters and titers tests your insurance is and is not required to cover under current federal law.
In March, we anticipated sunshine and warmer days while keeping up with the latest health policy research. We read about marketplace plan deductibles, physician turnover in private-equity acquired practices, and estimated savings from prescription drug rebates.
In February we stayed out of the cold and bundled up with the latest in health policy research. We read about salary and utilization changes in hospitals acquired by private equity, challenges with price transparency requirements, and changes to hospital community benefit rules in Oregon.
Since the snow shows no sign of stopping, we might as well stay cozy inside and read up on the latest health policy research from January! This month we read about patient care after private equity acquisition of hospitals, and how to improve risk-adjustment accuracy in Medicare Advantage.
A snowy first week of January gave us plenty of time to read some of the last research from 2024. This month we read about prescription drug pricing and the impacts of rebates on consumers, as well as market shares of Medicare Advantage carriers.
More hot days mean more hot research! This month we read about the growing divergence between Medicare Advantage bids and payments, the impact of enhanced premium tax credits by race and ethnicity, and about how narrow or broad ACA marketplace physician networks really are.
The days are heating up and so is the summer research! This month we read about the effects of health risk assessments on Medicare Advantage payments, how the Affordable Care Act transformed the healthcare landscape in this country, and finally, about hospital pricing and the values of transparency.
The opinions expressed here are solely those of the individual blog post authors and do not represent the views of Georgetown University, the Center on Health Insurance Reforms, any organization that the author is affiliated with, or the opinions of any other author who publishes on this blog.
